Collagen and HA-Based Biomaterials: A Global Strategic Business Report
San Jose, California (PRWEB) February 25, 2008
Biomaterials are considered one of the most exciting areas for medical devices. The future holds immense potential in terms of developing new products with wide application range. Novel and technological breakthroughs in fields such as "dermal implants" is expected to contribute to higher growth rates in terms of preference/choice of treatment in future. Competition from substitutes could hold up the growth pace in the collagen based biomaterials market. However, market expansion is supported by facial aesthetic dermal implants segment, which highlights a significant growth opportunity.
Growth in the biomaterials market continues to be fueled by heightened interest in personal healthcare, strong demographic shifts of aging population coupled with technological and process breakthroughs. United States represents the world's largest collagen and HA-based biomaterials market, accounting for over 40% of the global demand, as stated by Global Industry Analysts, Inc. Japan represents the second largest market, followed by Europe. Of the two broad product categories, hyaluronic acid based biomaterials overwhelmingly dominates the total market, with an 87% share estimated for 2007. The product group is also the faster moving. Within the Hyaluronic acid based biomaterials group, viscosupplements represents the dominant segment, with a market share of about 65%. Newly introduced HA-based facial aesthetic dermal implants represent the most promising market, with a robust CAGR of 20% over the next five years. In the collagen based biomaterials product group, facial aesthetic dermal implants comprises the largest segment. However, Botox and HA-based facial aesthetic dermal implants are posing stiff competition to collagen, resulting in negative growth for collagen-based dermal implants market.
Leading players in the global collagen and HA-based biomaterials market include Alcon Laboratories Inc, Anika Therapeutics, Inc., Bioniche Pharma USA LLC, Genzyme Biosurgery, Allergan Medical, Q-Med, and Seikagaku Corporation.
The report titled "Collagen and HA-Based Biomaterials: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides major trends and issues redefining the industry landscape, key statistical data, and status of various collagen and HA based products in the pipeline. The report also provides a brief review of key industry participants, respective market shares by select segment and region. Segments explored in the study include Collagen Based (Urinary Incontinence Products, Corneal Shields, Facial Aesthetic Dermal Implants and Wound Dressings) and Hyaluronic Acid Based (Viscosupplements, Viscoelastics, and Facial Aesthetic Dermal Implants) Biomaterials.
For more details about this research report, please visit http://www.strategyr.com/Collagen_and_HA-Based_Biomaterials_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com